Haemonetics Corporation 0.0% 01-MAR-2026Haemonetics Corporation 0.0% 01-MAR-2026Haemonetics Corporation 0.0% 01-MAR-2026

Haemonetics Corporation 0.0% 01-MAR-2026

No trades
See on Supercharts

HAE5381173 analysis



Key facts


Issue date
Mar 17, 2022
Maturity date
Mar 1, 2026
Outstanding amount
‪300.00 M‬USD
Face value
1,000.00USD
Minimum denomination
1,000.00USD
Coupon
0% (Zero)
Yield to maturity
6.42%
Haemonetics Corp. engages in the development and distribution of hematology products and solutions. It operates through the following segments: Plasma, Blood Center, and Hospital. The Plasma segment offers automated plasma collection and donor management software systems. The Blood Center segment provides solutions for donor collection centers' ability to acquire blood, filter blood, and separate blood components. The Hospital segment includes hemostasis management, cell salvage, and transfusion management services that help decision makers in hospitals optimize blood acquisition, storage, and usage in critical settings. The company was founded by Allen Latham, Jr. in 1971 and is headquartered in Boston, MA.
Go deeper with bond data
Access the most important data for bonds including coupon rates, issue ratings, redemption data and more.